Samsung to aim to become biopharmaceutical power

While the number of patents registered as biopharmaceutical product has continuously increased for the past 5 years, it was observed Samsung Electronics filed the most number of applications for antibody patent, also known as targeted antibiotics.

According to the Korean Intellectual Property Office’s present condition of application for antibody patent for the past 5 years, domestic large pat...